ClinicalTrials.gov
public full text
Public Domain
Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients
Morbidity and mortality in patients suffering from systemic inflammatory response syndrome (SIRS) remain high. The primary aim of the present study is to assess the efficacy of a standardized 5% serum-protein solution containing immunoglobulins on serum cytokine levels. The secondary aim is to evaluate survival of the patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease#879740
- Evaluating the Accuracy of Multiple Blood Tests to Diagnose Sepsis in Adult Burn Patients#1151683
- Composite Ratios Boost CRP's Power in Monitoring Ulcerative Colitis.#1139258
- May Nesfatin-1 be a biomarker in Acute mesenteric ischemia?#955727
- Remote Monitoring of IBD#857365
Record · ID 1007880
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive